DASH vs EW · P/E 76, rev $13.72B vs P/E 47, rev $1.39B
DoorDash, Inc. Class A Common Stock (DASH) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the DASH and EW stock pages for the full models.
Not investment advice.